Discover how UCB embraces the power of collaboration to consistently work towards improving patient outcomes and experiences.
Social determinants of health (SDOH) are the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.3
In general, SDOH factors may include access to4:
These patients deserve more visibility into the factors that limit their health and more ways to get the care they need. We are committed to leading that long-awaited change, and it starts with observing these needs in care disparities.
is limited due to legal discrimination7
to support the effect of epilepsy medications on gender-affirming hormonal treatments8
~50% of clinicians recognize sexual orientation and gender identity (SOGI) as SDOH8
who are knowledgeable and culturally competent in LGBTQIA+ health isa problem7
Quality of care, pricing, and epilepsy specialist availability vary widely by geographic area. In rural locations, access to specialists is especially restricted, making location key in receiving adequate healthcare.5
Surgery & Emergency
Room Visits
Access to Specialists
Only:
of African American patients
of Hispanic patients
Health equity needs to be prioritized. Measures to reduce disparities need action. Through collaboration with others, we are working to fill these gaps in care. Training physicians, nurses, and other healthcare workers on the social determinants of health is a tangible step to promote more equitable health outcomes. Let’s start broadening awareness of SDOH in epilepsy not only today, but every day.
About half of an individual’s outcome is comprised of socioeconomic factors and physical environment—meaning factors outside of healthcare delivery impact patient quality and length of life.19
Examination of mediating pathways through which SDOH influences epilepsy outcomes is needed to bring meaningful change.1 These pathways include:
Addressing these SDOH factors and pathways may improve access to care and population health outcomes, helping to fulfill health equity goals along the way.
Epilepsy isn’t only a burden on people; it’s a burden on our entire healthcare system.
Epilepsy-specific costs are 2.2x higher for uncontrolled epilepsy vs stable epilepsy 22†‡
*Estimate is based on a reported cost of $26 billion in 2013 converted to 2018 dollar value.22
†Retrospective claims study conducted between January 1, 2007, and December 31, 2009, with MarketScan commercial database representing all major regions of the United States.22
‡Uncontrolled: Added seizure medication to an existing regimen during year of observation; Stable: No change in seizure medication for at least 1 year.22
§Adjusted for baseline measures.
From: Higher HRU and Costs With Uncontrolled Epilepsy Study Design: Retrospective, longitudinal, matched-cohort analysis. Study Sample: US adults ≥18 years of age; 110,312 Medicaid population (matched cohorts, n=3454); 36,529 employer population (matched cohorts, n=602). Limitations: Work-loss estimates based on subset of commercial claims, potential selection bias per group assignment, excluded less severe seizures, adjusted to 2009 dollars.
Resources located in the Cultural Humility Toolkit are intended to help and guide both Healthcare Providers and minority patients. The Toolkit contains resources to help patients with epilepsy find the right doctor and have successful healthcare appointments.
Healthcare Providers will find a conversation guide, to help facilitate a culturally competent conversation with their minority patients with epilepsy. There are sample questions for both providers and patients. Feel free to choose the questions that best fit your situation.